Women in Science Series set – Beloit Daily News
By Dr. Matthew Watson
Women in Science Series set Beloit Daily News Paula Traktman, Ph.D., Walter Schroeder Professor and Chair of Microbiology and Molecular Genetics at MCW, will explain the intricate nature of viruses and how some can peacefully co-exist with humans, while others wreak havoc and cause devastating ... |
Tiny Piece of RNA Keeps ‘Clock’ Running in Earliest Stages of Life – Science Daily (press release)
By Dr. Matthew Watson
Tiny Piece of RNA Keeps 'Clock' Running in Earliest Stages of Life Science Daily (press release) "It's a big deal to find that a single interaction between a microRNA and its target has this very profound effect when you interfere with its function," said Susan Cole, associate professor of molecular genetics at The Ohio State University and lead ... |
Yes, a Child Has Been Pronounced Cured of HIV but Can It Be Duplicated?
By Dr. Matthew Watson
A child born to an HIV-infected mother in Mississippi may be cured after a swiftly administered course of drugs. A number of factors make the child’s case unique, however, and clinicians caution that we have not discovered a general cure for HIV yet. Still, the medical first may hint at ways to fight the AIDS-causing virus .
[More]
Source:
http://rss.sciam.com/click.phdo?i=95337d9798ea17db628f12536ca0a05b
Researchers Home in on Biological Ways to Restore Hearing [Excerpt]
By Dr. Matthew Watson
Editor’s Note: Excerpted from Shouting Won’t Help: Why I--and 50 Million Other Americans--Can’t Hear You , by Katherine Bouton, published by Sarah Crichton Books, an imprint of Farrar, Straus and Giroux, LLC. Copyright © 2013 Katherine Bouton. All rights reserved.
[More]
Source:
http://rss.sciam.com/click.phdo?i=26ba9d76b5b91ce8e95b09bea6e3b5c4
Cyberspace Makeover at California Stem Cell Agency
By Dr. Matthew Watson
California's $3 billion stem cell
agency has performed a well-done makeover on its most important
public face – its web site, which is chock-a-block full of useful
information for researchers and the unwashed alike.
words of its directors as they wrestle with everything from grant
approvals to conflicts of interest. Scientists can be seen telling
the story of their accomplishments. Money can be followed, and
summaries of reviews of grant applications read, both those approved
and those that did not pass muster.
Institute of Regenerative Medicine (the formal name of the agency) is the place where the stem cell program
really meets the public. News stories are important, but infrequent.
Day to day, however, thousands of interested persons seek out
information that the folks at CIRM HQ, just a long throw from the San
Francisco Giants ballpark, bring to cyberspace.
of the web site, 15,000 to 17,000 “unique viewers”
visit online. She told the California Stem Cell
Report in an email,
“We're up about 25 percent year over
year in unique viewers to the site. A lot of that growth comes from
search, and the rest is from traffic driven through our blog and
Facebook.”
those chalked up by major media sites. But they are significant
given that there are only a few thousand people worldwide who are
deeply and regularly interested in stem cell research. Many more,
however, are stimulated to look into the subject from time to time,
either because of news stories, personal, disease-related concerns or simple interest in cutting edge science. Engaging those
readers, who can spread the CIRM story, and winning their approval is
critical for the agency as it faces the need to raise more millions
as it money runs out in the next few years.
its short life. So much that good tools are needed to navigate the
site. Decisions about what should go on the home page are critical.
With the makeover, the agency now has a long-needed, home-page link to its
meetings , especially those of its governing board, which are the
single most important events at the agency.
new, white background makes it easier to read and is comfortable for
readers long conditioned to the black-on-white print of the books,
newspapers and magazines. The video image on the home page is larger,
which helps attract viewers. The site has long had a carload of
videos, some of which contain powerful and emotional stories from
patients.
new features. She reported,
“I've had people inside CIRM (who
have been beta testing this site) tell me that they are finding
content they'd never seen before because the site is so much easier
to navigate.”
also have pulled together important information on each grant on a
single page, including progress reports. You can find a sample here on a $1 million grant to Stanford's Helen Blau.
“Now people can not only
read about what our grantees are hoping to accomplish, they can read
about what has actually been accomplished with our funding.”
downloadable spread sheets of information that can be manipulated by
readers offline. She said,
“Most places on the site where you
see tables, you can now download those tables to Excel. You'll notice
the small Excel icon at the lower left of the table. This feature has
long been available for the searchable grants table. Now you'll see
it on all the tables of review reports (see here for
example http://www.cirm.ca.gov/application-reviews/10877)
on the disease fact sheets (see
here http://www.cirm.ca.gov/about-stem-cells/alzheimers-disease-fact-sheet)
and other places throughout the site. This is part of an effort to
make our funding records more publicly available.”
still needs work. A search using the term “CIRM budget 2012-2013”
did not produce a budget document on the first two pages of the
search results. A search on the term “Proposition 71,” the ballot
initiative that created CIRM, did not provide a direct link to its
text on the first two pages of search results.
as I can tell, is a list of the persons who appointed the past and
present board members as well as the dates of the board members'
terms of office. The biographies on some of the 29 governing board
members come up short. In the case of Susan Bryant, her bio does not
mention that she is interim executive vice chancellor and provost at
UC Irvine. Links also could be added to board members statements of economic interest. A list of CIRM staff members (only slightly more than 50
persons) and their titles could be added.
uses Google Analytics tools. Adams said,
“A unique visitor is Google's
definition (it's one of the metrics they provide). It's a visit from
a unique IP (internet protocol) address. So, if you visit our site
multiple times from one IP address during a day, you count as a
single unique visitor. (Editor's note: It is possible to have
more than one visitor from the same IP address.)
“We get ~23,000-25,000 visits per
month, or ~16,000-18,000 unique visitors. Page views are on the order
of 65,000 a month.”
is a worthy effort and enhances CIRM's relationships with all those
who come looking for information. The agency is to be commended and
should continue its work to improve the site and its connections with
the public.
California Stem Cell Directors to Finalize IOM Response Next Week
By Dr. Matthew Watson
Directors of the California stem cell
agency will meet March 19 in Burlingame to complete action on
their response to blue-ribbon recommendations for sweeping changes at
the eight-year-old research enterprise.
told the San Diego U-T editorial board that he regarded approval as
“largely ministerial.”
editorial boards around the state, touting his plan, which was
initially approved by the board in January. The main focus has been
on its provisions dealing with conflicts of interest, which would
have 13 of the 29 governing board members voluntarily remove themselves from
voting on any grant applications. The 13 are linked to recipient
institutions. Two other board members linked to recipient
institutions also sit on the board.
that has been awarded by the CIRM board has gone to institutions
linked to past and present members of the board.
problems with conflicts at the stem cell agency. It recommended
creation of a new, independent majority on the board, which would
mean that some members would lose their seats. The IOM report also
recommended a host of additional changes that have become eclipsed by
the controversy about conflicts, which were built into the board by
Proposition 71, the ballot measure that created it in 2004.
California Stem Cell Report of the IOM report, which CIRM
commissioned at a cost of $700,000, showed that agency's response fell far short of what the IOM proposed to improve the agency's
performance.
approval of applications in a $30 million effort by the agency
involving reprogrammed adult stem cells. The agency said the goal of
the initiative is “to generate and ensure the availability of high
quality disease-specific hiPSC resources for disease modeling, target
discovery and drug discovery and development for prevalent,
genetically complex diseases.”
Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/FH7dzoNWS8c/california-stem-cell-directors-to.html
San Diego Newspaper Hails Stem Cell Agency and IOM Response
By Dr. Matthew Watson
The $3 billion California stem cell
agency hit it big in San Diego today, finally scoring an editorial
that said “arguably” the agency's largess has made the state “the
world leader in medical research.”
circulation newspaper in the area, said the big headline about the
eight-year-old agency is “the potential for transformative medical
breakthroughs.”
long been criticized in connection with conflicts of interest. About
90 percent of the $1.8 billion the agency has awarded has gone to
institutions linked to current and past members of its board of
directors.
criticism seriously,” the newspaper said. It cited proposals that
would, if approved later this month, have 13 members of the agency's
governing board voluntarily abstain from voting on any grants that come before
the board. Twenty-nine persons sit on the board. The thirteen are
connected to recipient institutions. Two other board members are
linked to recipient institutions.
matter in San Diego, which is one of California's hotbeds of biotech
and stem cell research. The stem cell agency has awarded about $338
million to San Diego area institutions and businesses. Four
executives from San Diego area institutions sit on the CIRM board.
“There
remains a residue of cynicism about CIRM. Critics say the agency
board did the minimum necessary to avoid an intervention by the
Legislature – and also acted to buff the agency’s image should it
seek more bond funding from California voters before its present
funding runs out in 2017, as is now projected.
“These views
may have some merit. But on balance, we think the California
Institute for Regenerative Medicine has – at long last –
responded properly to the fair criticism it faced. Instead of being
exasperated by CIRM, more people should be excited about the great
work it is doing.”
involving the editorial board of the newspaper, CIRM Chairman
Jonathan Thomas and Larry Godlstein, director of the UC San Diego stem
cell program. The meeting was part of a CIRM campaign to generate
newspaper support for the agency's response to sweeping recommendations from a blue-ribbon study by the Institute of Medicine. The San Diego editorial is the most effusive so far.
Bradley Fikes, sat in on the meeting and Saturday posted video excerpts from the discussion, including a brief written summary of the content of each clip.
Local View: Governor’s support for SCID screening critical – Lincoln Journal Star
By Dr. Matthew Watson
Local View: Governor's support for SCID screening critical Lincoln Journal Star Research in 2011 by Chan et al. in Molecular Genetics and Metabolism found SCID screening was cost effective and would save 880 life years for each year of screening in the United States. But Samantha didn't have access to SCID screening and, ... |
Cell Therapy for Allogeneic Stem Cell Transplant by Dr Richard Champlin – Video
By JoanneRUSSELL25
Cell Therapy for Allogeneic Stem Cell Transplant by Dr Richard Champlin
Dr Richard Champlin, Professor and Chair of the department of Stem Cell Transplant and Cellular Therapy gave an update on the role of Cell Therapy in improvi...
By: TheMedalGroup
Read the original post:
Cell Therapy for Allogeneic Stem Cell Transplant by Dr Richard Champlin - Video
STEM CELL Therapy thru Laminine_Part-1(new link) – Video
By daniellenierenberg
STEM CELL Therapy thru Laminine_Part-1(new link)
STEM CELL Therapy thru laminine_part1new link. Uploaded by cabmon0001 on Mar 14 2013. cabmon 0001.
By: cabmon0001
Read more from the original source:
STEM CELL Therapy thru Laminine_Part-1(new link) - Video
Shining Red Mice Help Czechs Fight Bowel Cancer, Skin Disease – Sudan Vision
By Dr. Matthew Watson
![]() Sudan Vision | Shining Red Mice Help Czechs Fight Bowel Cancer, Skin Disease Sudan Vision A research group at the Institute of Molecular Genetics at the Czech Academy of Sciences is using proteins obtained from sea organisms like coral to light up mice and observe cell development under their skin without having to kill them. "We can take ... |
2013 Stem Cell Therapy #1 – Video
By daniellenierenberg
2013 Stem Cell Therapy #1
Introduction to 11 weeks of stem cell therapy in Delhi with Dr Geeta Shroff.
By: Louis Rowe
Follow this link:
2013 Stem Cell Therapy #1 - Video
STEM CELL Therapy thru Laminine_Part-2(new link) – Video
By JoanneRUSSELL25
STEM CELL Therapy thru Laminine_Part-2(new link)
STEM CELL Therapy thru laminine_part2new link. Uploaded by cabmon0001 on Mar 14 2013. cabmon 0001.
By: cabmon0001
Read the original:
STEM CELL Therapy thru Laminine_Part-2(new link) - Video
Dr Alok Sharma’s Stem Cell Therapy Treatment for Cerebral Palsy – Video
By LizaAVILA
Dr Alok Sharma #39;s Stem Cell Therapy Treatment for Cerebral Palsy
dr alok sharma stem cell therapy treatment for cerebral palsy He is a case of CP with history of fullterm C section delivery and normal milestones till eight months of age when he had an episode of febrile convulsions Post convulsions he had delayed milestones After Stem Cell Therapy 1 Irrelevant speech which was excessively present before has reduced post therapy 2 His level of understanding has increased and response to following commands has improved considerably upto 25% For eg after ...
By: neurogenbsi
Here is the original post:
Dr Alok Sharma's Stem Cell Therapy Treatment for Cerebral Palsy - Video
Dr Alok Sharma Stem Cell Therapy Treatment for Muscular Dystrophy – Video
By LizaAVILA
Dr Alok Sharma Stem Cell Therapy Treatment for Muscular Dystrophy
Dr Alok Sharma Stem Cell Therapy Treatment for Muscular Dystrophy She is a known case of MD with history of gradual onset of progressive lower extremities muscle weakness noticed since 27 years of age with complaints of imbalance while walking foot drop and difficulty in stair case climbing So she was investigated and muscle biopsy confirmed diagnosis of MD After Stem Cell Therapy 1 Stamina has increased Exercise tolerance has improved 2 She can lift her leg more up while in standing 3 Hip ...
By: neurogenbsi
Follow this link:
Dr Alok Sharma Stem Cell Therapy Treatment for Muscular Dystrophy - Video
Dr Alok Sharma Stem Cell Therapy Treatment for Muscular Dystrophy Before and After – Video
By NEVAGiles23
Dr Alok Sharma Stem Cell Therapy Treatment for Muscular Dystrophy Before and After
Dr Alok Sharma Stem Cell Therapy Treatment for Muscular Dystrophy Before and After After Stem Cell Therapy 1 Stamina has increased Exercise tolerance has improved 2 She can lift her leg more up while in standing 3 Hip flexion is easier and range has improved 4 Bending hip and knee in supine is easier 5 She can bring her leg forward in knee standing without support 6 Can now bring the knees to her chest 7 SLR range has improved Stem Cell Therapy done at Dr Alok Sharma neurogen Brain and ...
By: neurogenbsi
Read the original:
Dr Alok Sharma Stem Cell Therapy Treatment for Muscular Dystrophy Before and After - Video
Dr Alok Sharma Stem Cell Therapy for Duchenne Muscular Dystrophy in Gujarati – Video
By NEVAGiles23
Dr Alok Sharma Stem Cell Therapy for Duchenne Muscular Dystrophy in Gujarati
Dr Alok Sharma Stem Cell Therapy for Duchenne Muscular Dystrophy in Gujarati 16 years old male with history of frequent falls and being slow as compared to p...
By: neurogenbsi
See the article here:
Dr Alok Sharma Stem Cell Therapy for Duchenne Muscular Dystrophy in Gujarati - Video
Dr Alok Sharma Stem Cell Therapy Treatment for Cerebral Palsy – Video
By Dr. Matthew Watson
Dr Alok Sharma Stem Cell Therapy Treatment for Cerebral Palsy
Dr Alok Sharma Stem Cell Therapy Treatment for Cerebral Palsy He is a known case of Diplegic CP with history of full term normal delivery (vaccum) delivery a...
By: neurogenbsi
Continue reading here:
Dr Alok Sharma Stem Cell Therapy Treatment for Cerebral Palsy - Video
Prolotherapy | PRP | Stem Cell Therapy | The Prolotherapy Institute – prolotherapyinstitute.com – Video
By LizaAVILA
Prolotherapy | PRP | Stem Cell Therapy | The Prolotherapy Institute - prolotherapyinstitute.com
Prolotherapy | PRP | Stem Cell Therapy | The Prolotherapy Institute prolotherapyinstitutecom. Uploaded by Guillermo Mata on Mar 11 2013. Suffering from chronic pain Dr Darrow can help Prolotherapy | PRP | Stem Cell Therapy in Southern California Call The Prolotherapy Institute today Call Us Today to Make an Appointment800 7342210.
By: Guillermo Mata
See the original post:
Prolotherapy | PRP | Stem Cell Therapy | The Prolotherapy Institute - prolotherapyinstitute.com - Video
ReNeuron Group wins grants for stem cell therapy development
By raymumme
LONDON (SHARECAST) - ReNeuron Group has won two grants worth 1.2m pounds to develop its stem cell therapy.
The grants were awarded by the UK Biomedical Catalyst, a programme of public funding jointly managed by the Technology Strategy Board and the Medical Research Council.
The first award of 0.4m will be used for ReNeurons ReN009 stem cell therapy candidate for critical limb ischaemia, a severe blockage in the arteries which markedly reduces blood-flow to the extremities including hands, feet and legs.
The second award of 0.8m relates to the company's ReN003 stem cell candidate for the treatment of retinitis pigmentosa, an eye disease in which there is damage to the retina.
Michael Hunt, the Chief Executive Officer of ReNeuron, said: "We are delighted to have been successful in winning the two grants we applied for in the current round of the Biomedical Catalyst funding competition.
"This highly competitive scheme involves a rigorous peer review of applicants' technologies and commercial development plans.
"In common with other awardees, we therefore regard the grants as representing a strong independent endorsement of ReNeuron's world-class stem cell development capabilities which we hope will eventually lead to the wide-scale treatment of disease conditions where there is currently a very large unmet medical need."
Shares rose 0.86% to 2.94p at 08:52 Monday.
RD
See the original post here:
ReNeuron Group wins grants for stem cell therapy development